ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Veltassa®:Vifor Fresenius Medical Care Renal Pharma Ltd
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
V03AE09 - Patiromer CalciumATC-DDD Version 2016. Source: WHO
V - Various
 

This group comprises many different types of drugs, and assigning DDDs are difficult. Very few DDDs are assigned in this group.

V03 - All Other Therapeutic Products
 
V03A - All Other Therapeutic Products
 
V03AE - Drugs for Treatment Of Hyperkalemia and Hyperphosphatemia

Plain calcium products also used in hyperphosphatemia are classified in A12AA.

The DDD for lanthanum carbonate is expressed as lanthanum and is equivalent to 4.3 g lanthanum carbonate.
The DDD for ferric citrate is based on the recommended dose for chronic kidney disease patients not on dialysis.
The DDD for patiromer calcium is based on the recommended starting dose.

V03AE09 - Patiromer Calcium
Concentr.Adm.RouteNote
 O 
2024 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home